Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$2.02B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.37B |
| 3 |
Cigna
CI
|
+$1.08B |
| 4 |
JPMorgan Chase
JPM
|
+$1.04B |
| 5 |
WP
Worldpay, Inc.
WP
|
+$916M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$2.24B |
| 2 |
Amazon
AMZN
|
+$2.22B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.43B |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$1.1B |
| 5 |
Boeing
BA
|
+$591M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.85% |
| 2 | Technology | 15.62% |
| 3 | Communication Services | 12.99% |
| 4 | Consumer Discretionary | 11.83% |
| 5 | Industrials | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
AbbVie
ABBV
$435B
| $16B | 5.58% |
173,568,243
-2,571,964
| -1% | -$226M |
|
2
Microsoft
MSFT
$3.71T
| $11.2B | 3.89% |
109,862,947
+888,576
| +0.8% | +$95.2M |
|
|
3
Meta Platforms (Facebook)
META
$1.51T
| $9.15B | 3.19% |
69,772,523
+9,458,143
| +16% | +$1.37B |
|
4
Abbott
ABT
$187B
| $8.82B | 3.07% |
121,928,346
-3,241,452
| -3% | -$228M |
|
|
5
Amazon
AMZN
$2.96T
| $7.07B | 2.46% |
94,122,660
-26,667,660
| -22% | -$2.22B |
|
|
6
Netflix
NFLX
$309B
| $6.88B | 2.4% |
256,915,760
-74,908,800
| -23% | -$2.24B |
|
7
Amgen
AMGN
$222B
| $6.84B | 2.38% |
35,144,975
+722,277
| +2% | +$141M |
|
8
Broadcom
AVGO
$2.04T
| $6.43B | 2.24% |
252,733,660
-4,213,590
| -2% | -$99.4M |
|
|
9
Alphabet (Google) Class C
GOOG
$4.32T
| $5.27B | 1.84% |
101,867,300
-26,730,180
| -21% | -$1.43B |
|
10
Verizon
VZ
$196B
| $5.19B | 1.81% |
92,320,780
-7,178,424
| -7% | -$407M |
|
|
11
Alphabet (Google) Class A
GOOGL
$4.33T
| $5.03B | 1.75% |
96,176,540
-9,816,760
| -9% | -$531M |
|
12
UnitedHealth
UNH
$370B
| $4.79B | 1.67% |
19,233,851
+181,197
| +1% | +$47.9M |
|
13
Intel
INTC
$513B
| $4.58B | 1.6% |
97,608,743
-10,226,912
| -9% | -$479M |
|
14
Gilead Sciences
GILD
$165B
| $4.54B | 1.58% |
72,548,789
+2,693,821
| +4% | +$188M |
|
15
EOG Resources
EOG
$70.7B
| $3.99B | 1.39% |
45,736,385
+2,047,326
| +5% | +$219M |
|
16
ExxonMobil
XOM
$634B
| $3.78B | 1.32% |
55,423,969
+5,661,680
| +11% | +$444M |
|
17
Philip Morris
PM
$295B
| $3.67B | 1.28% |
54,912,758
+8,529,564
| +18% | +$712M |
|
18
Thermo Fisher Scientific
TMO
$220B
| $3.57B | 1.24% |
15,930,354
+38,359
| +0.2% | +$9M |
|
19
General Dynamics
GD
$106B
| $3.53B | 1.23% |
22,446,969
+1,736,703
| +8% | +$311M |
|
20
Nike
NKE
$61.9B
| $3.49B | 1.22% |
47,107,624
-7,242,197
| -13% | -$542M |
|
21
Coca-Cola
KO
$375B
| $3.35B | 1.17% |
70,763,302
+10,137,402
| +17% | +$485M |
|
22
Mastercard
MA
$493B
| $3.34B | 1.16% |
17,711,942
-1,736,562
| -9% | -$345M |
|
23
Altria Group
MO
$114B
| $3.24B | 1.13% |
65,581,429
-6,301,536
| -9% | -$365M |
|
24
Lowe's Companies
LOW
$125B
| $3.1B | 1.08% |
33,610,504
+1,920,259
| +6% | +$185M |
|
25
Alibaba
BABA
$308B
| $2.67B | 0.93% |
19,509,510
-1,903,935
| -9% | -$281M |
|
Similar funds
Capital Research Global Investors's Q4 2018 Portfolio in Review
As of Q4 2018, Capital Research Global Investors held 457 positions worth $287B, down 17% from $344B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Capital Research Global Investors's Q4 2018 filing shows 21 new, 162 increased, 169 reduced and 40 closed positions. Its largest new stake was Linde: 12,771,339 shares worth $1.99B. The largest sale was Netflix, an estimated $2.24B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q4 2018 buy was Linde: 12,771,339 shares worth $1.99B.
- Capital Research Global Investors added most to Meta Platforms (Facebook) in Q4 2018, an estimated $1.37B increase.
- Capital Research Global Investors's biggest Q4 2018 reduction was Netflix, cutting an estimated $2.24B.
- Capital Research Global Investors fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $1.1B.
- Capital Research Global Investors's ten largest holdings make up 29% of its $287B portfolio in Q4 2018.
- Capital Research Global Investors opened 21 new positions and closed 40 in Q4 2018.
- Capital Research Global Investors's portfolio value fell 17% quarter-over-quarter to $287B.
Based on Capital Research Global Investors's 13F filing for Q4 2018, filed 14 Feb 2019.